COVID-19 Updates
From the Journals
Newly defined liver disorder associated with COVID mortality
Conference Coverage
Robust immune response after COVID-19 boosters in those with IBD
Data support an additional vaccine dose of mRNA vaccine in patients at risk for an inadequate response to the initial series, says expert.
Conference Coverage
Two factors linked to higher risk of long COVID in IBD
Conference Coverage
Breakthrough COVID-19 milder in vaccinated patients with IBD
Patients with inflammatory bowel disease who are vaccinated but still develop COVID experience milder disease than those who are unvaccinated.
From the Journals
Gut bacteria linked with long COVID
From the Journals
Long COVID associated with risk of metabolic liver disease
Metabolic-associated fatty liver disease may be another cluster phenotype of long COVID.
Conference Coverage
Alcohol-related liver disease severity increased during COVID-19 pandemic
Increased alcohol sales and disrupted services may have led to worse clinical outcomes.
Conference Coverage
Immune response detected in most IBD patients after COVID vaccines
Overall, similar levels of antibodies were seen across vaccine type, age group, and medication class, with the exception of corticosteroids.
From the Journals
2021 AGA Rapid Review and Guideline Update: Pre-endoscopy SARS-CoV-2 testing post vaccination
The new guideline eases requirements for testing as vaccinations are rolled out in the interest of minimizing delays in care.
From the Journals
COVID-19: New GI symptoms don’t raise death risk in IBD
International registry data show new onset of GI symptoms is common in IBD patients with COVID-19 regardless of IBD disease status.